Together, the upregulated transcription of GABRA1, GABRA6, GAD2, GLRA2, and GLRA3 and downregulation of SLC6A13 strongly suggest increased inhibition in the ALS-Ox frontal and motor cortex. This evidence concerns the gene SLC6A13 and amyotrophic lateral sclerosis.